Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Daly EJ, Trivedi MH, Janik A, Li H, Zhang Y, Li X, Lane R, Lim P, Duca AR, Hough D, Thase ME, Zajecka J, Winokur A, Divacka I, Fagiolini A, Cubala WJ, Bitter I, Blier P, Shelton RC, Molero P, Manji H, Drevets WC, Singh JB. Daly EJ, et al. Among authors: bitter i. JAMA Psychiatry. 2019 Sep 1;76(9):893-903. doi: 10.1001/jamapsychiatry.2019.1189. JAMA Psychiatry. 2019. PMID: 31166571 Free PMC article. Clinical Trial.
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia.
Bitter I, Dossenbach MR, Brook S, Feldman PD, Metcalfe S, Gagiano CA, Füredi J, Bartko G, Janka Z, Banki CM, Kovacs G, Breier A; Olanzapine HGCK Study Group. Bitter I, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Jan;28(1):173-80. doi: 10.1016/j.pnpbp.2003.09.033. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 14687871 Clinical Trial.
Adverse reactions to duloxetine in depression.
Bitter I, Filipovits D, Czobor P. Bitter I, et al. Expert Opin Drug Saf. 2011 Nov;10(6):839-50. doi: 10.1517/14740338.2011.582037. Epub 2011 May 5. Expert Opin Drug Saf. 2011. PMID: 21545241 Review.
Pharmacological treatment of adult ADHD.
Bitter I, Angyalosi A, Czobor P. Bitter I, et al. Curr Opin Psychiatry. 2012 Nov;25(6):529-34. doi: 10.1097/YCO.0b013e328356f87f. Curr Opin Psychiatry. 2012. PMID: 22801362 Review.
Methylphenidate in mania project (MEMAP): study protocol of an international randomised double-blind placebo-controlled study on the initial treatment of acute mania with methylphenidate.
Kluge M, Hegerl U, Sander C, Dietzel J, Mergl R, Bitter I, Demyttenaere K, Gusmão R, Gonzalez-Pinto A, Perez-Sola V, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintão S, Edel MA, Bolyos C, Ayuso-Mateos JL, López-García P. Kluge M, et al. Among authors: bitter i. BMC Psychiatry. 2013 Feb 27;13:71. doi: 10.1186/1471-244X-13-71. BMC Psychiatry. 2013. PMID: 23446109 Free PMC article. Clinical Trial.
Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial.
Németh G, Laszlovszky I, Czobor P, Szalai E, Szatmári B, Harsányi J, Barabássy Á, Debelle M, Durgam S, Bitter I, Marder S, Fleischhacker WW. Németh G, et al. Among authors: bitter i. Lancet. 2017 Mar 18;389(10074):1103-1113. doi: 10.1016/S0140-6736(17)30060-0. Epub 2017 Feb 7. Lancet. 2017. PMID: 28185672 Clinical Trial.
A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study).
Hegerl U, Mergl R, Sander C, Dietzel J, Bitter I, Demyttenaere K, Gusmão R, González-Pinto A, Zorrilla I, Alocén AG, Sola VP, Vieta E, Juckel G, Zimmermann US, Bauer M, Sienaert P, Quintão S, Edel MA, Bolyos C, Ayuso-Mateos JL, López-García P, Kluge M. Hegerl U, et al. Among authors: bitter i. Eur Neuropsychopharmacol. 2018 Jan;28(1):185-194. doi: 10.1016/j.euroneuro.2017.11.003. Epub 2017 Nov 23. Eur Neuropsychopharmacol. 2018. PMID: 29174864 Clinical Trial.
212 results